Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Limited has announced a proposed issue of up to 9,375,000 new securities, including 3,125,000 options and 6,250,000 fully paid ordinary shares. The issuance is slated for December 13, 2024, and aims to bolster the company’s capital structure, potentially attracting investors looking for growth opportunities in the biotech sector.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Paramount Global (NASDAQ:PARA) Adds an Ad-Supported Tier in Europe
- How Ford (NYSE:F) Looks to Solve Its Hydrogen Engine Problem
- The Intel (NASDAQ:INTC) “Coffee Debacle” Is Now Solved
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
